FDA Urged To Block Unapproved Post-Surgery Injections
The U.S. Food and Drug Administration must swiftly block sales of an unapproved injectable drug sold by Fresenius Kabi AG, Cardinal Health Inc. and other companies because the post-surgery product is...To view the full article, register now.
Already a subscriber? Click here to view full article